Thomas Jaquin Email

Group Leader (Associate Director) Preclinical Pharmacology and Biomarker Development . iOmx Therapeutics

Martinsried/ Munich,

Location

Current Roles

Employees:
85
Revenue:
$17.1M
About
iOmx is a new-age start-up biotech company in the immuno-oncology field. We are focused on innovation-driven research to advance our proprietary early stage novel immune-checkpoint molecules through pre-clinical and clinical development. Follow this page to keep yourself updated about our journey as we advance in creating next-generation immunotherapy treatments for cancer patients. Imprint: https://iomx.com/imprint
iOmx Therapeutics Address
Fraunhoferstrasse 13
Martinsried/ Munich, null
iOmx Therapeutics Email